1. Multidisciplinary Management of Hyperkalemia:

3. Program Goals

4. Hyperkalemia: The Gray Zone -- Underappreciated

5. Hyperkalemia: Episode or Long-Term Consequence?

6. The Emergency Department: Home for Acute Hyperkalemia

7. ED: Potassium Levels Severity, Treatment, and Outcomes

8. What Was Learned

9. Hyperkalemia: The Continuum Clinical Presentation for In-Patient or Primary Care

10. Severe Hyperkalemia

11. Guidelines Recommendations Regarding RAAS Inhibitor Use Based on Serum Potassium Level

12. Hyperkalemia in PARADIGM-HF

13. Finding the Balance: Hypokalemia or Hyperkalemia

14. Relationship Between Potassium Level and Patient Outcome

15. Acute Treatment of Hyperkalemia

16. Causes of Hyperkalemia

17. Balancing RAAS Inhibitor Use and Potassium Level

18. Spironolactone and Hyperkalemia

19. Patiromer Structure

20. ZS-9 Structure

21. Comparison of SPS, Patiromer, and ZS-9

22. PEARL-HF: Patients With HF Receiving Standard Therapy and Spironolactone Treated With Patiromer

23. New Potassium Binders and Prevention of Hyperkalemia Unanswered Questions and Clinical Implications

24. Transition of Care with Hyperkalemia From Acute to Chronic Care

25. Abbreviations

26. Abbreviations (cont)

27. Abbreviations (cont)